We are live on ! Find out more
Fidelity International

Fidelity International Portfolio holdings

AUM $129B
1-Year Est. Return 30.83%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$72.1B
AUM Growth
+$6B
Cap. Flow
+$642M
Cap. Flow %
0.89%
Top 10 Hldgs %
20.97%
Holding
1,050
New
131
Increased
432
Reduced
355
Closed
45

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$459M
2
SHOP icon
Shopify
SHOP
+$376M
3
LEN icon
Lennar Class A
LEN
+$307M
4
MO icon
Altria Group
MO
+$207M
5
GLD icon
SPDR Gold Trust
GLD
+$205M

Sector Composition

Rank Sector Weight
1 Technology 20.01%
2 Financials 17.47%
3 Consumer Discretionary 12.93%
4 Healthcare 8.79%
5 Communication Services 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
751
Regeneron Pharmaceuticals
REGN
$72.9B
$8K ﹤0.01%
21
+1
+5% +$336
MRTX
752
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8K ﹤0.01%
+65
New +$6.27K
ARQL
753
DELISTED
Arqule Inc
ARQL
$8K ﹤0.01%
+413
New +$4.79K
WLK icon
754
Westlake Corp
WLK
$9.25B
$7K ﹤0.01%
95
-22,988
-100% -$1.54M
NVRO
755
DELISTED
NEVRO CORP.
NVRO
$7K ﹤0.01%
+62
New +$6.14K
SWAV
756
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$7K ﹤0.01%
+153
New +$5.65K
XLRN
757
DELISTED
Acceleron Pharma
XLRN
$7K ﹤0.01%
+124
New +$5.65K
BBY icon
758
Best Buy
BBY
$18.9B
$6K ﹤0.01%
68
+7
+11% +$536
CPRI icon
759
Capri Holdings
CPRI
$1.88B
$6K ﹤0.01%
171
+3
+2% +$104
IOVA icon
760
Iovance Biotherapeutics
IOVA
$2.1B
$6K ﹤0.01%
+223
New +$5.07K
MO icon
761
Altria Group
MO
$125B
$6K ﹤0.01%
132
-4,378,498
-100% -$207M
NBIX icon
762
Neurocrine Biosciences
NBIX
$18.4B
$6K ﹤0.01%
+53
New +$5.55K
NLY icon
763
Annaly Capital Management
NLY
$17.4B
$6K ﹤0.01%
149
PRGO icon
764
Perrigo
PRGO
$1.43B
$6K ﹤0.01%
127
SIRI icon
765
SiriusXM
SIRI
$10.7B
$6K ﹤0.01%
90
TAK icon
766
Takeda Pharmaceutical
TAK
$56B
$6K ﹤0.01%
311
WBA
767
DELISTED
Walgreens Boots Alliance
WBA
$6K ﹤0.01%
116
-3
-3% -$173
SGEN
768
DELISTED
Seagen Inc. Common Stock
SGEN
$6K ﹤0.01%
+50
New +$5.3K
ACAD icon
769
Acadia Pharmaceuticals
ACAD
$4.45B
$5K ﹤0.01%
+112
New +$4.87K
AMP icon
770
Ameriprise Financial
AMP
$48.3B
$5K ﹤0.01%
31
+2
+7% +$310
BMRN icon
771
BioMarin Pharmaceuticals
BMRN
$12B
$5K ﹤0.01%
+59
New +$4.46K
COF icon
772
Capital One
COF
$130B
$5K ﹤0.01%
43
+4
+10% +$385
EXPE icon
773
Expedia Group
EXPE
$35.5B
$4K ﹤0.01%
38
-9
-19% -$1.06K
FURY
774
Fury Gold Mines
FURY
$99.2M
$4K ﹤0.01%
+1,350
New +$2.69K
RL icon
775
Ralph Lauren
RL
$22.5B
$4K ﹤0.01%
33
+1
+3% +$105

Similar funds

Fidelity International's Q4 2019 Portfolio in Review

As of Q4 2019, Fidelity International held 1,050 positions worth $72.1B, up 9.1% from $66.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Fidelity International's Q4 2019 filing shows 131 new, 432 increased, 355 reduced and 45 closed positions. Its largest new stake was Darling Ingredients: 6,419,639 shares worth $180M. The largest sale was Royal Bank of Canada, an estimated $459M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Fidelity International's largest Q4 2019 buy was Darling Ingredients: 6,419,639 shares worth $180M.
  • Fidelity International added most to Canadian Natural Resources in Q4 2019, an estimated $553M increase.
  • Fidelity International's biggest Q4 2019 reduction was Royal Bank of Canada, cutting an estimated $459M.
  • Fidelity International fully exited Celgene Corp in Q4 2019, selling an estimated $141M.
  • Fidelity International's ten largest holdings make up 21% of its $72.1B portfolio in Q4 2019.
  • Fidelity International opened 131 new positions and closed 45 in Q4 2019.
  • Fidelity International's portfolio value rose 9.1% quarter-over-quarter to $72.1B.

Based on Fidelity International's 13F filing for Q4 2019, filed 7 Feb 2020.